Portal Our Laboratories

ANSES has taken part in preclinical trials of a potential vaccine against sarbecoviruses, the coronaviruses responsible for severe acute respiratory syndrome. In hamsters, this vaccine was equally effective against all the SARS-CoV-2 variants studied. These results suggest the potential for vaccines whose protection does not diminish with the appearance of new SARS-CoV-2 variants or new sarbecoviruses.

A multitude of players are involved in the surveillance of pathogenic bacteria that can be transmitted through food, from farm to fork. The European MATRIX project, which has just come to an end, sought to improve collaboration between the various bodies involved in the surveillance systems set up in each European country.

Many discoveries about bacteria of the Brucella genus have been made in recent years: new species have been discovered, others that were already known have been detected in animals not known to carry these bacteria, and species such as Brucella canis are emerging in Western Europe. Could these bacteria be transmitted to humans? Which animal species are concerned? How can these bacteria be distinguished from each other? These questions were the focus of the European IDEMBRU project, coordinated by ANSES as part of the One Health EJP programme.

The combined use of several different software applications could speed up the acquisition of knowledge on toxins known as mycotoxins, which are produced by certain types of mould growing in food. This innovative approach has been used by ANSES scientists to identify mycotoxins that may be mutagenic and/or carcinogenic.